United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 4 minute read Pharma Industry News GSK India delivers 32% profit surge—Zejula and Jemperli launches set to transform cancer care GSK India reports 32% PAT growth in FY25; read how oncology launches and vaccine growth are shaping the company’s future outlook. byPallavi MadhirajuMay 14, 2025